New York Life Trust’s Medtronic MDT Stock Holding History

New York Life Trust’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$3K	Sell	37 -481	-93%	-$37.6K	0.15%	155
2016 Q4	$37K	Sell	518 -72	-12%	-$5.66K	0.18%	152
2016 Q3	$51K	Buy	590 +130	+28%	+$11.3K	0.25%	127
2016 Q2	$40K	Sell	460 -10	-2%	-$809	0.19%	155
2016 Q1	$35K	Buy	470 +24	+5%	+$1.81K	0.15%	173
2015 Q4	$34K	Buy	446 +6	+1%	+$452	0.15%	162
2015 Q3	$29K	Buy	440 +26	+6%	+$1.92K	0.13%	163
2015 Q2	$31K	Sell	414 -46	-10%	-$3.52K	0.13%	166
2015 Q1	$36K	Buy	+460	New	+$34.9K	0.14%	160
2014 Q1	–	Sell	-823	Closed	-$47K	–	215
2013 Q4	$47K	Buy	823 +784	+2,010%	+$44.5K	0.21%	148
2013 Q3	$2K	Sell	39 -123	-76%	-$6.62K	0.01%	184
2013 Q2	$8K	Buy	+162	New	+$8.01K	0.04%	191

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

New York Life Trust's MDT Position: Q1 2017 in Review

New York Life Trust reduced its Medtronic (MDT) stake by 93% in Q1 2017, selling an estimated $37.6K and leaving 37 shares worth $3K. The position accounts for 0.15% of the portfolio, ranked #155.

New York Life Trust first reported a position in MDT in Q2 2013 and has held it in 12 quarters since. The position peaked at $51K in Q3 2016. 1,284 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

New York Life Trust held 37 shares of Medtronic worth $3K as of Q1 2017.
New York Life Trust sold 481 Medtronic shares in Q1 2017, an estimated $37.6K.
Medtronic made up 0.15% of New York Life Trust's portfolio in Q1 2017, its #155 holding.
New York Life Trust first reported a position in Medtronic in Q2 2013 and has held it in 12 quarters since.
New York Life Trust's Medtronic position peaked at $51K in Q3 2016.
1,284 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.